Genetic/familial high-risk assessment: Breast and ovarian
National Comprehensive Cancer Network, Inc.
Genetic/familial high-risk assessment: Breast and ovarian, in NCCN Practice Guidelines in Oncology, M.B. Daly, Editor, 2003, National Comprehensive Cancer Network, Inc. www.nccn.org.
Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: Analysis of 10,000 individuals
6
TS Frank 2002 Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals J Clin Oncol 20 6 1480 90
A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO
6
DG Evans 2004 A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO J Med Genet 41 6 474 80
BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes
11
DA Berry 2002 BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes J Clin Oncol 20 11 2701 12
Linkage of a pedigree drawing program and database to a program for determining BRCA mutation carrier probability
San Francisco: The University of Chicago Press
Sand SR et al. Linkage of a pedigree drawing program and database to a program for determining BRCA mutation carrier probability. In Proceedings of American Society of Human Genetics 1999 Annual Meeting. San Francisco: The University of Chicago Press, 1999.